Liu, Mei <br/><br/>
Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  11 2017 
 - 1354-1363 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1530-0307 
<br/><br/><label>Standard No.: </label>10.1038/labinvest.2017.70  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--antagonists & inhibitors<br/>Adult<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Biomarkers, Tumor--metabolism<br/>Brain Neoplasms--diagnosis<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cohort Studies<br/>Enzyme Activation--drug effects<br/>Female<br/>Glioma--diagnosis<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Nerve Tissue Proteins--antagonists & inhibitors<br/>Phosphoproteins--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Prognosis<br/>Protein Processing, Post-Translational--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Transcription Factors<br/>YAP-Signaling Proteins